V. Loustaud

1.3k total citations
25 papers, 489 citations indexed

About

V. Loustaud is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, V. Loustaud has authored 25 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Rheumatology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in V. Loustaud's work include Vasculitis and related conditions (11 papers), Systemic Lupus Erythematosus Research (5 papers) and Renal Diseases and Glomerulopathies (3 papers). V. Loustaud is often cited by papers focused on Vasculitis and related conditions (11 papers), Systemic Lupus Erythematosus Research (5 papers) and Renal Diseases and Glomerulopathies (3 papers). V. Loustaud collaborates with scholars based in France, Switzerland and Italy. V. Loustaud's co-authors include É. Liozon, K.H. Ly, P. Soria, Elisabeth Vidal, François R. Herrmann, Pierre‐Yves Robert, Éric Vidal, F Liozon, P. Weinbreck and Marie‐Odile Jauberteau and has published in prestigious journals such as The Lancet, The American Journal of Medicine and eLife.

In The Last Decade

V. Loustaud

23 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Loustaud France 11 283 219 104 90 58 25 489
GSRSNK Naidu India 13 222 0.8× 166 0.8× 63 0.6× 60 0.7× 48 0.8× 66 493
Hirofumi Takei Japan 13 207 0.7× 365 1.7× 225 2.2× 89 1.0× 19 0.3× 23 539
Yasmina Ferfar France 10 337 1.2× 241 1.1× 129 1.2× 49 0.5× 15 0.3× 12 582
Stefania Colantuono Italy 13 131 0.5× 187 0.9× 152 1.5× 92 1.0× 28 0.5× 34 595
Meral Koniçe Türkiye 18 239 0.8× 496 2.3× 100 1.0× 48 0.5× 47 0.8× 38 934
P. Carli France 7 115 0.4× 199 0.9× 51 0.5× 45 0.5× 28 0.5× 26 414
M. Debandt France 8 186 0.7× 300 1.4× 41 0.4× 89 1.0× 16 0.3× 12 547
V. Rieu France 11 123 0.4× 183 0.8× 61 0.6× 98 1.1× 31 0.5× 30 476
M. Pha France 10 55 0.2× 341 1.6× 39 0.4× 62 0.7× 65 1.1× 29 481
Elaine C. Tozman United States 10 75 0.3× 306 1.4× 40 0.4× 12 0.1× 23 0.4× 11 492

Countries citing papers authored by V. Loustaud

Since Specialization
Citations

This map shows the geographic impact of V. Loustaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Loustaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Loustaud more than expected).

Fields of papers citing papers by V. Loustaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Loustaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Loustaud. The network helps show where V. Loustaud may publish in the future.

Co-authorship network of co-authors of V. Loustaud

This figure shows the co-authorship network connecting the top 25 collaborators of V. Loustaud. A scholar is included among the top collaborators of V. Loustaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Loustaud. V. Loustaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marotel, Marie, Marine Villard, Issam Tout, et al.. (2021). Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion. eLife. 10. 30 indexed citations
2.
Liozon, É., K.H. Ly, H. Bézanahary, et al.. (2010). Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families.. PubMed. 27(1 Suppl 52). S89–94. 34 indexed citations
3.
Liozon, É., G. Gondran, K.H. Ly, V. Loustaud, & Elisabeth Vidal. (2008). Duration of Treatment After Eye Involvement in Giant Cell Arteritis. The Journal of Rheumatology. 35(6). 1220–1221. 3 indexed citations
4.
Sparsa, A., É. Liozon, Janine Wechsler, et al.. (2006). Aortic angiosarcoma clinically mimicking polyarteritis nodosa. Scandinavian Journal of Rheumatology. 35(3). 237–240. 11 indexed citations
6.
Denizot, Yves, É. Liozon, Laurence Guglielmi, et al.. (2003). No evidence for a putative involvement of platelet‐activating factor in systemic lupus erythematosus without active nephritis. Mediators of Inflammation. 12(2). 101–105. 2 indexed citations
7.
Bézanahary, H., et al.. (2002). Lupus érythémateux disséminé et herpes viridae : à propos de trois observations. La Revue de Médecine Interne. 23(12). 1018–1021. 6 indexed citations
8.
Liozon, É., François R. Herrmann, K.H. Ly, et al.. (2001). Facteurs prédictifs de complications céphaliques ischémiques irréversibles au cours de la maladie de Horton : étude prospective sur 178 patients. La Revue de Médecine Interne. 22(1). 30–41. 5 indexed citations
9.
Liozon, É., V. Loustaud, Marie‐Odile Jauberteau, et al.. (2001). Lymphomes malins et syndrome des antiphospholipides non simultanés : quatre observations. La Revue de Médecine Interne. 22(4). 360–370. 11 indexed citations
10.
Liozon, É., François R. Herrmann, K.H. Ly, et al.. (2001). Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. The American Journal of Medicine. 111(3). 211–217. 148 indexed citations
11.
Denes, É., et al.. (2000). Une cervicalgie calcique. La Revue de Médecine Interne. 21(11). 1001–1002. 2 indexed citations
12.
Liozon, É., P. Roblot, V. Loustaud, et al.. (2000). Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases. Lara D. Veeken. 39(10). 1089–1094. 55 indexed citations
13.
Denes, É., et al.. (2000). Nécroses digitales bilatérales et symétriques : penser au cancer. La Revue de Médecine Interne. 21. 551–552. 1 indexed citations
14.
Liozon, É., P. Soria, Valérie Gissot, et al.. (2000). [Horton's disease and hypereosinophilic syndrome: a non-fortuitous association].. PubMed. 151(7). 603–605. 1 indexed citations
15.
Liozon, É., et al.. (1999). «Complètement dément?…». La Revue de Médecine Interne. 20. 260s–263s. 2 indexed citations
16.
Liozon, É., Mohamed Touati, Nathalie Gachard, et al.. (1998). Thymoma-associated pancytopenia: effectiveness of cyclosporine A. Annals of Hematology. 77(4). 175–178. 15 indexed citations
17.
Gaches, F., V. Loustaud, Éric Vidal, et al.. (1993). Périatérite noueuse et infection par le parvovirus B19. La Revue de Médecine Interne. 14(5). 323–325. 14 indexed citations
18.
Liozon, F, et al.. (1992). Les décès dans la maladie de Horton, Facteurs de pronostic. La Revue de Médecine Interne. 13(3). 187–191. 9 indexed citations
19.
Vidal, Éric, R. Cévallos, Dominique Bordessoule, et al.. (1988). [Antithyrotropin receptor antibodies in a series of Basedow's disease].. PubMed. 139(5). 331–5. 2 indexed citations
20.
Liozon, F, Éric Vidal, É. Liozon, & V. Loustaud. (1988). Les présentations atypiques de la maladie de Horton. La Revue de Médecine Interne. 9(3). 239–241. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026